ArticleInfection & chemotherapy2026

Long-Term Effectiveness and Tolerability of Dolutegravir/Lamivudine in Korea: A 3-Year Follow Up Study.

Jae Eun Seong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.